根据协议，双方将在沙特阿拉伯分别设立商业化和生产合资公司，并在中东北非土耳其（MENAT）地区就复宏汉霖的一系列产品，包括阿达木单抗汉达远（HLX03）、贝伐珠单抗汉贝泰（HLX04），进行合作开发，开展本地注册、生产及商业化。另外，此次合作框架中的首批项目亦包括共同投资开发复宏汉霖自研的帕博利珠单抗生物类似药HLX17，共同推动该产品的全球注册上市。

We will strive together to create a sustainable and resilient healthcare ecosystem in the MENAT region, fostering a culture of safety, efficiency, and excellence.” The collaboration will involve ...

AdExchanger is where marketers, agencies, publishers and tech companies go for the latest information on the trends that are transforming digital media and marketing, from data, privacy, identity and ...

According to the agreement, Henlius and SVAX will establish joint ventures for commercialization and manufacturing in Saudi ...

C3 – Companies Creating Change, in collaboration with HSBC, has launched the C3 Net Zero Catalyst Program, aimed at ...

Jad Daou will lead the UM High-Growth Unit, a part of the agency's plans to drive business impact for clients with ...

Together, by combining SVAX's extensive resources and local expertise in MENAT with Henlius' global outlook and innovative capabilities, we are poised to bring more high-quality, innovative ...